Current Neuro-Oncology
Volume
5 Number 4
30 April 2003
Home > Publications > Current Neuro-Oncology > Volume 5, Year 2003 > Number 4, 30 April
Nutt CL, Mani DR, Betensky RA,
Tamayo P, Cairncross JG, Ladd C, Pohl U, Hartmann C, McLaughlin
ME, Batchelor TT, Black PM, von Deimling A, Pomeroy SL, Golub TR,
Louis DN.
Gene
expression-based classification of malignant gliomas correlates
better with survival than histological classification.
Cancer
Res. 2003 Apr 1;63(7):1602-7∟.
PMID: 12670911∟.
Laboratory investigation. ∟
Westphal M, Hilt DC, Bortey E,
Delavault P, Olivares R, Warnke PC, Whittle IR, Jääskeläinen
J, Ram Z.
A
phase 3 trial of local chemotherapy with biodegradable carmustine
(BCNU) wafers (Gliadel wafers) in patients with primary malignant
glioma.
Neuro
Oncol. 2003 Apr 1;5(2):79-88∟.
doi: 10.1093/neuonc/5.2.79∟.
PMID: 12672279∟.
Phase 3 trial. ∟
Taylor RE, Bailey CC, Robinson K,
Weston CL, Ellison D, Ironside J, Lucraft H, Gilbertson R, Tait
DM, Walker DA, Pizer BL, Imeson J, Lashford LS; International
Society of Paediatric Oncology; United Kingdom Children's Cancer
Study Group.
Results
of a randomized study of preradiation chemotherapy versus
radiotherapy alone for nonmetastatic medulloblastoma: The
International Society of Paediatric Oncology/United Kingdom
Children's Cancer Study Group PNET-3 Study.
J
Clin Oncol. 2003 Apr 15;21(8):1581-91∟.
doi: 10.1200/JCO.2003.05.116∟.
PMID: 12697884∟.
Prospective study. ∟